Usefulness of oral kanamycin for retrograde infection after biliary stent placement

Usefulness of oral kanamycin for retrograde infection after biliary stent placement - Usefulness of oral kanamycin for stent occlusion

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002375

Enrollment

Registered

2009-09-01

Start date

2009-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive jaundice

Interventions

plastic stent - oral kanamycin in group plastic stent - group without oral kanamycin metal stent - oral kanamycin in group metal stent - group without oral kanamycin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: For obstructive jaundice, patients requiring long-term biliary stent placement.

Exclusion criteria

Exclusion criteria: 1.patients already have oral kanamycin prior to stenting 2.history of upper gastrointestinal 3.patients with hearing loss 4.severe renal dysfunction (serum creatinine> 2.0mg/dl) the merger of the patient 5.patients unable to take oral medication 6.pregnant women, nursing mothers, and pregnant women suspected 7.other patients deemed inappropriate for this exam by the doctor

Design outcomes

Primary

Measure	Time frame
biliary stent occlusion	—

Countries

Japan

Contacts

Public Contactshingo kato

Yokohama City University Hospital Gastroenterology Division

045-787-2800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026